Mary Caffrey

The phenomenon of "yo-yo" dieting has health consequences and frustrates dieters themselves. Studies show each round of weight loss and weight regain produces harsher metabolic effects.

The physicians said the American Medical Association abandoned a core mission of protecting patients by endorsing a nominee who wants to roll back Medicaid expansion and privatize Medicare.

The study found that avoiding 3 key risk factors-diabetes, obesity, and hypertension-by age 45, greatly increased the likelihood of avoiding heart failure through the end of life.

The study found young adults had the lowest device uptake, as well as highest distress levels and the highest A1C.

In New Jersey, a group of business and labor leaders-along with the state's largest health plan-decided it was time for the term "patient-centered" to be understood by a key constituency: patients themselves.

Early results published Tuesday were first presented this summer at the meeting of the American Diabetes Association.

Awareness of Medicaid eligibility rules meant that in 2014 alone, more than 2 million people enrolled for benefits who belonged in the program but for some reason had never signed up.

The statement calls for delivery behavioral health services through a collaborative model when possible, both to share electronic health data and offer convenience and continuity for patients.

While smoking has long been known to aggravate diabetes, the new study shows just how deadly the habit is for those with the chronic condition.

Some estimates put the market for insulin and GLP-1 combination therapy at $1 billion.

Scientists compared genomes of more than 20,000 people with schizophrenia and 20,000 without the mental disorder to uncover the variants associated with the disease.

The matchstick-size pump has been heralded as a game changer in addressing the biggest problem in diabetes care: medication adherence.

The authors leave open the possibility that current reporting systems are not catching the impact of all medication errors. A different study earlier this year found that medical errors, including those that involve medication, caused so many deaths that the CDC should change its reporting methods to account for them.

The meeting in New Orleans featured surprising clinical findings and some attention-grabbing consumer news.

Earlier this month, 2 members of Congress called for the Justice Department and the Federal Trade Commission to examine whether the major insulin manufacturers are coordinating on prices.

Public health officials scrutinize obesity rates among young children as an indicator of how efforts to combat the epidemic are faring overall.

The report did not break out the number of overdose deaths, but prior information said that 2014 had the most overdose deaths on record.

Studies of the effect of diet soda on diabetes and obesity have produced mixed results.

A study inspired by a patient who could not afford his heart medication shows that there was no pattern to price variability for a common regimen to treat heart failure, which could contribute to poor adherence.

For some time, cardiologists have wondered whether there was anything to be gained by pushing LDL or "bad" cholesterol to very low levels.

A study of a pair of large databases shows a strong link between obesity and heart failure.

The study finds one-quarter of the patients stop taking anticoagulants within 3 months and nearly three-quarters have stopped after 2.25 years.

The results point to the need for more study on the effects of long-duration blood pressure treatment to prevent cognitive decline, especially in the highest risk patients.

The results from a wide-ranging public health effort in Howard County, Maryland, show a decline in sugary beverage consumption nearly on par with early results from Berkeley, California, which passed the nation's first soda tax.

A review of data of patients with cardiomyopathy found that those who had used marijuana were more likely to be younger males with fewer pre-existing cardiovascular risk factors.

A transition statement on healthcare makes no mention of prescription drug prices, despite Trump's strong positions as a candidate. A pharmaceutical executive, former Christie Administration Chief of Staff Rich Bagger, took leave in July to run the Trump transition.

A new wearable medical device helped patients replace a stress response that is lost for those with type 2 diabetes.

Comments on the draft recommendation on obesity screening are being accepted through November 28, 2016.

The ban on insurers using pre-existing conditions to deny coverage is hugely popular with voters in both parties.

Scientific collaboration with Janssen Pharmaceuticals could reveal solutions to block the progression of diseases like Alzheimer's.